The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia

被引:12
作者
Gong Xubo
Lu Xingguo [1 ]
Wu Xianguo [2 ]
Xu Rongzhen
Xiao Xibin
Wang Lin [2 ]
Zhu Lei
Zhang Xiaohong
Xu Genbo
Zhao Xiaoying
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Hematol, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Dept Clin Lab, Hangzhou 310009, Peoples R China
基金
中国国家自然科学基金;
关键词
atypical chronic myeloid leukemia; chronic granulocytic leukemia; chronic myelomonocytic leukemia; bone marrow trephine biopsy; bone marrow aspirate; peripheral blood; CLASSIFICATION; GUIDELINES;
D O I
10.1111/j.1600-0609.2009.01283.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To better realize the features of peripheral blood (PB), bone marrow (BM) aspirate and especially BM trephine biopsy in atypical chronic myeloid leukemia (aCML). Methods: We studied PB, BM smears in 35 cases of aCML and compared with 84 cases of chronic granulocytic leukemia chronic phase (CGL-CP), 39 cases of chronic myelomonocytic leukemia (CMML). In addition, we evaluated characteristics of BM trephine biopsies in 21 cases of aCML and compared with 68 cases of CGL-CP, 20 cases of CMML. Results: All aCML patients presented with leukocytosis (median WBC 17.3 x 10<SU9</SU/L), 48% had moderate anemia, and 85% had thrombocytopenia. Values of monocytes, eosinophils, basophils, percentage of immature granulocytes and monocytes (0.63 +/- 0.41 x 10<SU9</SU/L, 0.18 +/- 0.16 x 10<SU9</SU/L, 0.09 +/- 0.08 x 10<SU9</SU/L, 6.27 +/- 3.09%, and 2.46 +/- 1.75%, respectively) were useful in distinguishing aCML from CGL-CP and CMML groups. The BM smears showed that striking dysgranulopoieis (100%), dyserythropoiesis (48.6%), percentage of blasts, nucleated erythrocytes, monocytes, eosinophils, and basophils (2.45 +/- 2.06%, 7.76 +/- 2.89%, 1.30 +/- 1.21%, 1.47 +/- 1.60%, and 1.15 +/- 1.08%, respectively) were all important parameters for a diagnosis of aCML. On BM trephine sections, aCML was characterized as hypercellularity, a moderate degree of reticulin fibrosis (71.4%), lymphocytopenia (76.2%), plasmacytopenia (90.5%), abnormal localization of immature precursors (28.5%), and absence of eosinophilia, basophilia, monocytosis. Furthermore, BM imprints, immunohistochemical, and cytochemical staining findings provided important morphological reference to BM trephine sections and made the identification of nucleated cells more convenient. Conclusions: Besides the findings observed in PB and BM aspirate, features of BM trephine biopsy (including BM trephine section, BM imprint, immunohistochemical, and cytochemical staining) can also aid in the diagnosis of aCML.
引用
收藏
页码:292 / 301
页数:10
相关论文
共 23 条
[1]   THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, H ;
SULTAN, C ;
COX, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) :746-754
[2]  
Breccia M, 2006, HAEMATOLOGICA, V91, P1566
[3]   Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm [J].
Fend, Falko ;
Horn, Thomas ;
Koch, Ina ;
Vela, Teresa ;
Orazi, Attilio .
LEUKEMIA RESEARCH, 2008, 32 (12) :1931-1935
[4]   HEMATOLOGICAL DIFFERENCES BETWEEN CHRONIC GRANULOCYTIC-LEUKEMIA, ATYPICAL CHRONIC MYELOID-LEUKEMIA, AND CHRONIC MYELOMONOCYTIC LEUKEMIA [J].
GALTON, DAG .
LEUKEMIA & LYMPHOMA, 1992, 7 (5-6) :343-350
[5]   Clinical, hematological and cytogenetic characteristics of atypical chronic myeloid leukemia [J].
Hernández, JM ;
del Cañizo, MC ;
Cuneo, A ;
García, JL ;
Gutiérrez, NC ;
González, M ;
Castoldi, G ;
San Miguel, JF .
ANNALS OF ONCOLOGY, 2000, 11 (04) :441-444
[6]   ICSH guidelines for the standardization of bone marrow specimens and reports [J].
Lee, S. -H. ;
Erber, W. N. ;
Porwit, A. ;
Tomonaga, M. ;
Peterson, L. C. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (05) :349-364
[7]  
Maíllo A, 2001, CANCER-AM CANCER SOC, V92, P377, DOI 10.1002/1097-0142(20010715)92:2<377::AID-CNCR1333>3.0.CO
[8]  
2-W
[9]   Myelodysplastic/myeloproliferative disorders [J].
Malcovati, Luca ;
Cazzola, Mario .
HAEMATOLOGICA, 2007, 93 (01) :4-+
[10]   RETICULIN CONTENT OF BONE-MARROW IN ACUTE-LEUKEMIA IN ADULTS [J].
MANOHARAN, A ;
HORSLEY, R ;
PITNEY, WR .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 43 (02) :185-&